Engineering a Cancer-Free World
The CAR-TCR drug development field has achieved huge success over the past year with regulatory approval in the US, Europe, Japan and Australia proving the potential these drugs have to successfully cure patients around the globe.
What is the CAR-TCR Summit?
Returning to Boston for the 6th year, the CAR-TCR Summit is a world-renowned conference bringing together over 1000 industry leaders developing CAR-TCR based therapies. Join pharma, biotech, regulatory bodies, academia, solution and service providers to discuss the next generation candidates beyond CD19, from solid tumor indications to autoimmune disorders.
How will it help you deliver on the promise of personalized CAR-TCR therapies to cure patients in need?
Across 4-days, you will hear 150 speakers present case-study led presentations, chair interactive discussions and lead practical workshops on what the most innovative and next generation companies are focusing on from bench to bedside as they strive to bring CAR-T and TCR therapies to market.
Gain an in depth breakdown of the current strategies to optimize the durability, persistence and targeting of approved and novel therapies to reduce relapse rates and overcome toxicity, as well as how to streamline process development and logistics supply chains for affordable and accessible CAR-TCR therapeutics.
Why you should attend?
If you are a dedicated drug developer committed to engineering a cancer-free world, this is your one stop shop to gain the tools and connections you need to maximize the potential of your cell immunotherapy pipeline and deliver a cure to patients globally.
The CAR-TCR Experience
Pre-Event Strategic Dives
Strategic dives are 15 engaging, discussion-based and data driven workshops, each focusing on a different aspect of the CAR-TCR drug development process spanning discovery through to commercialization.
This is an intimate and interactive opportunity to ask your questions and gain actionable insights on key challenges including:
- Submitting IND submissions
- Affinity and signalling selection
- Persistence of allogenic therapies
2 Summit Days: 6 Tracks
In order to provide your team with the most comprehensive and complete roadmap to CAR-T and TCR drug development, the two main summit days are divided across 6 tracks of content:
- Clinical Management – new!
Bring your team to divide and conquer ensuring your whole company can benefit from the full range of world-class expertise being showcased.
Post-Event Focus Day
A dedicated opportunity across 3 tracks to further explore the biggest opportunities in the field.
Join the likes of GSK, Johnson & Johnson, Cellectis, bluebird bio and Kite to shine a spotlight on the hottest topics:
- Targeting Solid Tumors
- Gene Editing Technologies
- TCR-T Cell Drug Development
An invaluable opportunity to take your knowledge a step further and continue networking with like-minded individuals who's work is focused in these areas.